John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.

Prior to joining Delphi, John was President and CEO of EndoTex Interventional Systems, Inc. (acquired by Boston Scientific Corporation) a development stage, venture backed, start-up company where he redirected the technology, resized the team and raised more than $50.0 million over six years through a series of venture capital, technology licensing, and corporate partnership financings. From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS). While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation.

EDUCATION

• B.S. Mechanical Engineering, University of California, Davis

REPRESENTATIVE BOARD INVOLVEMENT

• Acclarent, Inc.
• EndoTex Interventional Systems, Inc. (NYSE: BSX)
• Interventional Rhythm Management, Inc.
• InnerPulse, Inc.
• Paracor Medical, Inc.
• Primaeva Medical, Inc.
• VytronUS, Inc.